1. Home
  2. TG vs ACHV Comparison

TG vs ACHV Comparison

Compare TG & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tredegar Corporation

TG

Tredegar Corporation

HOLD

Current Price

$7.81

Market Cap

353.3M

Sector

Industrials

ML Signal

HOLD

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$4.69

Market Cap

172.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TG
ACHV
Founded
1988
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
353.3M
172.0M
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
TG
ACHV
Price
$7.81
$4.69
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$14.67
AVG Volume (30 Days)
191.1K
1.2M
Earning Date
05-08-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
151.06
N/A
EPS
0.17
N/A
Revenue
$800,821,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$46.97
N/A
Revenue Growth
8.29
N/A
52 Week Low
$6.25
$2.00
52 Week High
$10.53
$6.15

Technical Indicators

Market Signals
Indicator
TG
ACHV
Relative Strength Index (RSI) 39.31 50.17
Support Level $7.30 $4.65
Resistance Level $8.04 $4.98
Average True Range (ATR) 0.56 0.42
MACD -0.20 -0.11
Stochastic Oscillator 20.55 20.16

Price Performance

Historical Comparison
TG
ACHV

About TG Tredegar Corporation

Tredegar Corp is engaged in the manufacture of aluminum extrusions and polyethylene and polypropylene plastic films. It produces surface protection films, packaging films and films for other markets. The company continues to have two reportable segments: Aluminum Extrusions and High Performance Films. The majority of the revenue is derived form the Aluminum Extrusions segment which produces high-quality, soft and medium strength alloyed aluminum extrusions, custom fabricated and finished, for the building and construction, automotive and transportation, consumer durables goods, machinery and equipment, electrical and renewable energy, and distribution markets.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: